Reduction of Calciprotein Particles in Adults Receiving Infliximab for Chronic Inflammatory Disease

Patients with chronic inflammatory diseases (CID) experience accelerated loss of bone mineral density, which is often accompanied by increased vascular calcification. These disturbances can be attenuated by therapies for inflammation, such as the tumor necrosis factor inhibitor infliximab. Calciprot...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:JBMR Plus
Autors principals: Tiong, Mark K, Smith, Edward R, Toussaint, Nigel D, Al‐Khayyat, Hasan F, Holt, Stephen G
Format: Artigo
Idioma:Inglês
Publicat: John Wiley & Sons, Inc. 2021
Matèries:
Original Articles
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC8216135/
https://ncbi.nlm.nih.gov/pubmed/34189386
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jbm4.10497
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars